Cargando…
Serum VEGF Predicts Worse Clinical Outcome of Patients with Coronary Heart Disease After Percutaneous Coronary Intervention Therapy
BACKGROUND: Percutaneous coronary intervention (PCI) is an effective treatment for coronary heart disease (CHD) patients. However, patients after PCI treatment often have ischemic events that result in poor prognosis. Our study aimed to investigate the effects of vascular endothelial growth factor (...
Autores principales: | Han, Xia, Liu, Lili, Niu, Jiamin, Yang, Jun, Zhang, Zengtang, Zhang, Zhiqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627363/ https://www.ncbi.nlm.nih.gov/pubmed/26501555 http://dx.doi.org/10.12659/MSM.894803 |
Ejemplares similares
-
Association between Phosphatase Related Gene Variants and Coronary Artery Disease: Case-Control Study and Meta-Analysis
por: Han, Xia, et al.
Publicado: (2014) -
Prognostic Value of VEGF in Patients Submitted to Percutaneous Coronary Intervention
por: Ramos, Catarina, et al.
Publicado: (2014) -
Effects of Percutaneous Coronary Intervention on Serum Angiopoietin-2 in Patients with Coronary Heart Disease
por: Zeng, Zhi-Yu, et al.
Publicado: (2016) -
Predictive value of cardiopulmonary fitness parameters in the
prognosis of patients with acute coronary syndrome after percutaneous coronary
intervention
por: Niu, Suping, et al.
Publicado: (2020) -
Serum Calprotectin Levels and Outcome Following Percutaneous Coronary Intervention in Patients with Diabetes and Acute Coronary Syndrome
por: Wang, Chengji, et al.
Publicado: (2019)